Evaluation of concurrent and adjuvant carboplatin with radiation therapy for locally advanced cervical cancer.

[1]  A. Dueñas-González,et al.  A phase I study of carboplatin concurrent with radiation in FIGO stage IIIB cervix uteri carcinoma. , 2003, International journal of radiation oncology, biology, physics.

[2]  R. Higgins,et al.  Concurrent carboplatin with pelvic radiation therapy in the primary treatment of cervix cancer. , 2003, Gynecologic Oncology.

[3]  H. Steed.  Radical vaginal trachelectomy and laparoscopic pelvic lymphadenectomy for preservation of fertility , 2003 .

[4]  D. Parkin,et al.  Global cancer statistics in the year 2000. , 2001, The Lancet. Oncology.

[5]  P. Grigsby,et al.  Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  B N Bundy,et al.  Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  P. Eifel.  Concurrent chemotherapy and radiation: a major advance for women with cervical cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  B N Bundy,et al.  Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. , 1999, The New England journal of medicine.

[9]  P J Eifel,et al.  Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. , 1999, The New England journal of medicine.

[10]  B N Bundy,et al.  Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. , 1999, The New England journal of medicine.

[11]  E. Sartori,et al.  Continuous infusion of carboplatin during conventional radiotherapy treatment in advanced squamous carcinoma of the cervix uteri IIB-IIIB (UICC). A phase I/II and pharmacokinetic study. , 1997, American journal of clinical oncology.

[12]  S. Formenti,et al.  Carboplatin as a radiation sensitizer in locally advanced cervical cancer: a pilot study. , 1997, Gynecologic oncology.

[13]  B. Corn,et al.  Phase I/II study of concomitant irradiation and carboplatin for locally advanced carcinoma of the uterine cervix: an interim report. , 1996, American journal of clinical oncology.

[14]  R. Pearcey,et al.  Effect of cisplatin on the clinically relevant radiosensitivity of human cervical carcinoma cell lines. , 1996, International journal of radiation oncology, biology, physics.

[15]  P. Grigsby,et al.  Carcinoma of the uterine cervix. II. Lack of impact of prolongation of overall treatment time on morbidity of radiation therapy. , 1996, International journal of radiation oncology, biology, physics.

[16]  E Wiltshaw,et al.  Carboplatin dosage: prospective evaluation of a simple formula based on renal function. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  E. Douple,et al.  A REVIEW OF INTERACTIONS BETWEEN PLATINUM COORDINATION COMPLEXES AND IONIZING RADIATION: IMPLICATIONS FOR CANCER THERAPY , 1980 .

[18]  S. Crooke,et al.  Cisplatin : current status and new developments , 1980 .

[19]  Cockcroft Dw,et al.  Prediction of Creatinine Clearance from Serum Creatinine , 1976 .

[20]  G. Fletcher,et al.  Analysis of sites and causes of failures of irradiation in invasive squamous cell carcinoma of the intact uterine cervix. , 1975, Radiology.